Affymetrix, Inc.: Company Profile and SWOT Analysis

Document Sample
Affymetrix, Inc.: Company Profile and SWOT Analysis Powered By Docstoc
					Affymetrix, Inc.

_________________________________________________________________________________



Affymetrix, Inc.                                                          Financial Snapshot

                                                                          Operating Performance
Fast Facts
                                  3420 Central Expressway, Santa Clara,   The company reported revenues of US$310.75 million
Headquarters Address
                                  95051,United States of America          during 2010, with a CARC of -3.30% during 2006–
                                                                          2010. Its revenue declined at an annual rate of 5.00%
Telephone                         + 1 408 7315000
                                                                          over the previous fiscal year. In 2010, the company
                                                                          recorded an operating margin of 0.36%, as against -
Fax                               + 1 408 7315380                         4.80% in 2009.

Website                           www.affymetrix.com
                                                                          Revenue and Margins
Ticker Symbol, Stock Exchange     AFFX, NASDAQ

Number of Employees               918

Fiscal Year End                   December

Revenue (in US$ million)          310.75




SWOT Analysis

Strengths                         Weaknesses                              Return on Equity

Proprietary technology            Decrease in cash and cash equivalent    The company recorded a return on equity (ROE) of -
                                                                          3.48% for 2010, as compared to its peers, Johnson &
                                                                          Johnson (Ticker: JNJ), bioMerieux S.A. (Ticker: BIM)
Strategic Acquisitions            Dependence on the US market             and Beckman Coulter, Inc. (Ticker: BEC), which
                                                                          recorded ROEs of 23.57%, 16.33% and 10.82%
Strong research and development
                                  Weak top-line performance               respectively. The company reported an operating
activities
                                                                          margin of 0.36% in 2010.
Opportunities                     Threats
                                                                          Return on Equity
Changing demographics             Foreign exchange risk

New product launches              Government regulations

Potential market                  Industry Consolidation

Strategic partnership with FSI    Intense competition

                                  Reliance on suppliers




                                                                          Liquidity Position

                                                                          The company reported a current ratio of 3.90 in 2010,
                                                                          as compared to its peers, Johnson & Johnson,
                                                                          bioMerieux S.A. and Beckman Coulter, Inc., which
                                                                          recorded current ratios of 2.05, 1.76 and 2.15
                                                                          respectively. As of December 2010, the company
                                                                          recorded cash and short-term investments of worth
                                                                          US$102.71 million, against zero current debt. The
                                                                          company reported a debt to equity ratio of 0.33 in
                                                                          2010 as compared to its peers, Johnson & Johnson,
                                                                          bioMerieux S.A. and Beckman Coulter, Inc., which
                                                                          recorded debt to equity ratios of 0.30, 0.05 and 0.63
                                                                          respectively.




___________________________________________________________________________________________

Affymetrix, Inc. - SWOT Profile                                                                                  Page 1
Affymetrix, Inc.

_________________________________________________________________________________


TABLE OF CONTENTS

1     Business Analysis ................................................................................................................................... 5
    1.1       Company Overview ................................................................................................................................................5
    1.2       Business Description ..............................................................................................................................................5
    1.3       Major Products and Services .................................................................................................................................6
2     Analysis of Key Performance Indicators ............................................................................................... 7
    2.1       Five Year Snapshot: Overview of Financial and Operational Performance Indicators ..........................................7
    2.2       Key Financial Performance Indicators .................................................................................................................10
      2.2.1       Revenue and Operating Profit .........................................................................................................................10
      2.2.2       Asset, Liabilities and Capex .............................................................................................................................11
      2.2.3       Net Debt vs. Gearing Ratio ..............................................................................................................................12
      2.2.4       Operational Efficiency ......................................................................................................................................13
      2.2.5       Solvency ..........................................................................................................................................................14
      2.2.6       Valuation ..........................................................................................................................................................15
    2.3       Competitive Benchmarking ..................................................................................................................................16
      2.3.1       Efficiency ..........................................................................................................................................................17
      2.3.2       Capital Expenditure ..........................................................................................................................................18
      2.3.3       Turnover – Inventory and Asset .......................................................................................................................19
      2.3.4       Liquidity ............................................................................................................................................................20
3     Mergers & Acquisitions and Partnerships ........................................................................................... 21
    3.1       M&A and Partnerships Strategy ...........................................................................................................................21
4     Recent Developments ........................................................................................................................... 32
5     SWOT Analysis ...................................................................................................................................... 34
    5.1       SWOT Analysis - Overview ..................................................................................................................................34
    5.2       Strengths ..............................................................................................................................................................34
    5.3       Weaknesses .........................................................................................................................................................34
    5.4       Opportunities ........................................................................................................................................................35
    5.5       Threats .................................................................................................................................................................36
6     History .................................................................................................................................................... 38
7     Affymetrix, Inc. - Key Employees ......................................................................................................... 40
8     Key Employee Biographies................................................................................................................... 41
9     Locations and Subsidiaries .................................................................................................................. 42
    9.1       Head Office .......................................................................
				
DOCUMENT INFO
Description: This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business. ICD Research's "Affymetrix, Inc.: Company Profile and SWOT Analysis" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
BUY THIS DOCUMENT NOW PRICE: $99 100% MONEY BACK GUARANTEED
PARTNER ICD Research
With emphasis on Insight, Consultancy and Delivery, iCD Research is a full-service, online market research agency. iCD Research is able to take advantage of all of the efficiencies and benefits that the Internet brings to offer proven research methodologies with fast turnaround and accurate results. iCD Research specialises in qualitative research for large finance, media, retail and entertainment clients. Market leaders in online focus groups, iCD Research has unleashed the full scale of the Internet to run focus groups across the globe for its major institutional clients. Utilising its sister organisation, The iD Factor, iCD Research also delivers strong quantitative research, ranging from ongoing consumer confidence studies through to consumer surveys throughout Europe and Asia. With its roots firmly in research, iCD Research doesn’t limit itself to only utilising online methods as the philosophy at the company is to match the methodology to the respondent. Yet the scale and speed of online research give iCD Research a cutting edge that has lead to tremendous, triple-figure percentage growth over the past two years. iCD Research is headquartered in London, with operational offices in the US and Australia to ensure that it is offering an unparalleled 24 hour service to its clients.